Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a Tech-Powered home program help stroke survivors walk better?

NCT ID NCT07623018

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a gait training program delivered partly at home using a sensor and exercises is feasible and acceptable for people who have had a stroke. Twelve participants in Saudi Arabia will first train in a clinic, then continue at home for four weeks. The goal is to see if they can stick with the program and if it is safe, not yet to prove it improves walking.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
STEP-Tech intervention (telerehabilitation gait training program using Heel2Toe sensor and exercises)
What this could lead to
If successful, this could show that a home-based, tech-supported gait program is practical and acceptable for stroke survivors, paving the way for larger studies to improve walking recovery.
What could go wrong
This is a very small, early feasibility study with only 12 participants, so results may not apply to all stroke survivors. It does not yet test whether the program actually improves walking.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2027

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For stage one of the study: * People with stroke aged \> 18 years living in Saudi Arabia. * Diagnosed with ischemic or haemorrhagic stroke. * People with stroke in the late-subacute or chronic phase ( ≥ 3 months after stroke onset). * Patients can walk indoors for at least 10 meters with supervision and/or an assistive device (cane or walker). * Patient with low fall risk (less than 20 seconds) based on the Timed Up and Go test (TUG). * Ability to understand instructions and follow simple commands to participate in the study and give consent. Patients are required to obtain a score of seven or eight on the eight decisional capacity questionnaires that are relevant to the consent form content. These requirements are necessary to make sure that people can give consent. The decisional capacity questionnaire's content is based on the previously utilised University of California Brief Assessment Capacity to Consent (UBACC) questions that have been adjusted for the study's context. * They are not currently participating in any other stroke rehabilitation study. * Only those who can speak Arabic or English. For stage 2 of the study (qualitative evaluation): * Physiotherapists with experience working with people who have had a stroke (at least 2 years of experience). * Carers aged 18 years or older who support patients during the intervention period * Able to communicate in Arabic or English Exclusion Criteria: For stage one of the study : * Patient with severe spasticity and contracture in the lower extremity (Modified Ashworth Scale 3 or 4). * Unable to understand instructions to participate in the study and to give consent (due to severe cognitive impairments). * Severe communication deficit or complete aphasia. * Patients have another neurological condition (e.g., multiple sclerosis or Parkinson's disease) or a pre-stroke health condition that includes a gait disorder. * Serious medical comorbidities such as pulmonary and heart disease, and uncontrolled hypertension. For stage 2 of the study (qualitative evaluation): * Physiotherapists with insufficient experience (less than 2 years' experience) in stroke rehabilitation. * Carers who are unable to communicate well or have communication difficulties. * Carers who are unable to give consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    2 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aseer Rehabilitation Centre

    Abhā, Southern Region, Saudi Arabia

  • Sultan Bin Abdulaziz Humanitarian City (SBAHC)

    Riyadh, Saudi Arabia

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.